ELV Quote, Financials, Valuation and Earnings

Clover Health Investments has a net margin of 4.47% compared to Elevance Health's net margin of -6.56%. Elevance Health's return on equity of 14.03% beat Clover Health Investments's return on equity of -13.55%.

Elevance Health has a consensus price target of $505.55, signalling upside risk potential of 18.43%. On the other hand Clover Health Investments has an analysts' consensus of $4.75 which suggests that it could grow by 37.28%. Given that Clover Health Investments has higher upside potential than Elevance Health, analysts believe Clover Health Investments is more attractive than Elevance Health.

Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison Clover Health Investments has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.55%. Clover Health Investments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Clover Health Investments pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $48.9B, which are larger than Clover Health Investments quarterly revenues of $337M. Elevance Health's net income of $2.2B is higher than Clover Health Investments's net income of -$22.1M. Notably, Elevance Health's price-to-earnings ratio is 16.66x while Clover Health Investments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.54x versus 1.29x for Clover Health Investments. Usually stocks with elevated PS ratios are considered overvalued.

Centene has a net margin of 4.47% compared to Elevance Health's net margin of 0.69%. Elevance Health's return on equity of 14.03% beat Centene's return on equity of 12.3%.

Elevance Health has a consensus price target of $505.55, signalling upside risk potential of 18.43%. On the other hand Centene has an analysts' consensus of $79.50 which suggests that it could grow by 27.98%. Given that Centene has higher upside potential than Elevance Health, analysts believe Centene is more attractive than Elevance Health.

Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison Centene has a beta of 0.529, suggesting its less volatile than the S&P 500 by 47.066%.

Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.55%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $48.9B, which are larger than Centene quarterly revenues of $40.8B. Elevance Health's net income of $2.2B is higher than Centene's net income of $283M. Notably, Elevance Health's price-to-earnings ratio is 16.66x while Centene's PE ratio is 9.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.54x versus 0.20x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 4.47% compared to Elevance Health's net margin of 2.39%. Elevance Health's return on equity of 14.03% beat Molina Healthcare's return on equity of 25.84%.

Elevance Health has a consensus price target of $505.55, signalling upside risk potential of 18.43%. On the other hand Molina Healthcare has an analysts' consensus of $354.32 which suggests that it could grow by 6.72%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.

Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.701, suggesting its less volatile than the S&P 500 by 29.866%.

Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.55%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $48.9B, which are larger than Molina Healthcare quarterly revenues of $10.5B. Elevance Health's net income of $2.2B is higher than Molina Healthcare's net income of $251M. Notably, Elevance Health's price-to-earnings ratio is 16.66x while Molina Healthcare's PE ratio is 16.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.54x versus 0.47x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 4.47% compared to Elevance Health's net margin of 5.74%. Elevance Health's return on equity of 14.03% beat UnitedHealth Group's return on equity of 21.74%.

Elevance Health has a consensus price target of $505.55, signalling upside risk potential of 18.43%. On the other hand UnitedHealth Group has an analysts' consensus of $568.65 which suggests that it could grow by 34.02%. Given that UnitedHealth Group has higher upside potential than Elevance Health, analysts believe UnitedHealth Group is more attractive than Elevance Health.

Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.293%.

Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.55%. UnitedHealth Group offers a yield of 1.96% to investors and pays a quarterly dividend of $2.10 per share. Elevance Health pays 25.22% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $48.9B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Elevance Health's net income of $2.2B is lower than UnitedHealth Group's net income of $6.3B. Notably, Elevance Health's price-to-earnings ratio is 16.66x while UnitedHealth Group's PE ratio is 17.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.54x versus 0.97x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.